2017
Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes
Yonkers KA, Gilstad-Hayden K, Forray A, Lipkind HS. Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes. JAMA Psychiatry 2017, 74: 1145-1152. PMID: 28903165, PMCID: PMC5710298, DOI: 10.1001/jamapsychiatry.2017.2733.Peer-Reviewed Original ResearchConceptsSerotonin reuptake inhibitor useAdverse birth outcomesLow birth weightSerotonin reuptake inhibitorsWeeks of pregnancyHypertensive diseaseDuration of gestationRespiratory interventionsVentilatory supportCesarean deliveryReuptake inhibitorsPanic disorderPregnancy outcomesInhibitor usePreterm birthBirth outcomesBenzodiazepine treatmentBirth weightAnxiety disordersWorld Mental Health Composite International Diagnostic InterviewPrevious adverse birth outcomesComposite International Diagnostic InterviewAdverse pregnancy complicationsMaternal panic disorderNeonatal pregnancy outcomes
2015
Obstetric and Neonatal Outcomes After Antipsychotic Medication Exposure in Pregnancy
Coughlin CG, Blackwell KA, Bartley C, Hay M, Yonkers KA, Bloch MH. Obstetric and Neonatal Outcomes After Antipsychotic Medication Exposure in Pregnancy. Obstetrics And Gynecology 2015, 125: 1224-1235. PMID: 25932852, PMCID: PMC4418034, DOI: 10.1097/aog.0000000000000759.Peer-Reviewed Original ResearchConceptsAdverse birth outcomesGestational-age birthsAntipsychotic exposureNeonatal outcomesCohort studyBirth outcomesAntipsychotic medicationMajor malformationsBirth weightOdds ratioAntipsychotic medication exposureNeonatal birth weightPooled odds ratioPotential risk factorsUnexposed pregnanciesMedication exposurePreterm deliveryGestational ageAntipsychotic treatmentElective terminationPossible confoundersReproductive ageRisk factorsSpontaneous abortionSTUDY SELECTION